Zoster Treatment Market Analysis

  • Report ID: 3620
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

Zoster Treatment Market Analysis

The market is segmented by treatment type into antiviral medications, narcotic medications, anti-inflammatory medications, antihistamines, anticonvulsants, creams, and Zostavax, out of which, the antiviral medications segment is anticipated to hold the largest share in the global zoster treatment market. This can be accounted to the ability of these medications to shorten the length of a viral infection, and their effectiveness in shortening the course of several viral illnesses. Additionally, on the basis of route of administration, the oral segment is predicted to acquire the largest share during the forecast period. Acyclovir, famciclovir and valacyclovir are some of the most common drugs for treating zoster, which are taken via oral route of administration. This in turn is largely forecasted to drive the growth of the market segment in the future. 

Our in-depth analysis of the global market includes the following segments:

           Treatment Type

  • Antiviral Medications
  • Narcotic Medications
  • Anti-Inflammatory Medications
  • Antihistamines
  • Anticonvulsants
  • Creams
  • Zostavax

             End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

 

 

           Route of Administration

  • Oral
  • Parenteral
  • Topical
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3620
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving market growth are high prevalence of zoster globally and rising introduction of vaccines and medications for self-treatment.

The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2022 – 2030.

High cost of zoster treatment is estimated to hamper the market growth.

Asia Pacific will provide more business opportunities for market growth owing to the growing occurrence of herpes zoster, and rising initiatives by governmental and non-governmental organizations associated with vaccination drives.

The major players in the market are Valeant Pharmaceuticals North America, LLC, Merck & Co., Inc., Abbott Laboratories, Teva Pharmaceutical Ltd, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample